Opioid suppression of conditioned anticipatory brain responses to breathlessness

NeuroImage

Volumn 150, Issue , 2017, Pages 383-394

  Hayen, Anja ^a,b   Wanigasekera, Vishvarani ^a,c   Faull, Olivia K ^a   Campbell, Stewart F ^c   Garry, Payashi S ^a   Raby, Simon J M ^c   Robertson, Josephine ^a   Webster, Ruth ^c   Wise, Richard G ^d   Herigstad, Mari ^a,e   Pattinson, Kyle T S ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anticipation; Breathing; Breathlessness; Conditioning; FMRI; Opioid

Indexed keywords

OPIATE RECEPTOR; REMIFENTANIL; SODIUM CHLORIDE; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; AMYGDALA; ANTERIOR CINGULATE; ANTERIOR INSULA; ARTICLE; AVERSION; BRAIN FUNCTION; BRAIN STEM; BREATHING; CONDITIONED ANTICIPATORY BRAIN RESPONSE; CONDITIONING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INFUSION; DYSPNEA; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; NERVE CELL NETWORK; NEUROIMAGING; NORMAL HUMAN; NUCLEUS ACCUMBENS; OPERCULUM (BRAIN); PERCEPTION; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; RESPIRATION CONTROL; RIGHT HEMISPHERE; SENSORY CORTEX; STATE DEPENDENT LEARNING; VISUAL STIMULATION; VOLUNTEER; BRAIN; CONDITIONED REFLEX; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FUNCTIONAL NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS, OPIOID; BRAIN; CONDITIONING, CLASSICAL; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PIPERIDINES;

EID: 85014496761     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2017.01.005     Document Type: Article

References (87)

1. Aslan, S., Xu, F., Wang, P.L., Uh, J., Yezhuvath, U.S., van Osch, M., Lu, H., Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magn. Reson. Med. 63 (2010), 765–771.
2. Atlas, L.Y., Bolger, N., Lindquist, M.A., Wager, T.D., Brain mediators of predictive cue effects on perceived pain. J. Neurosci. 30 (2010), 12964–12977.
3. Bingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M.C., Ploner, M., Tracey, I., The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci. Transl. Med., 3, 2011, 70ra14.
4. Bond, A., Lader, M., Use of analog scales in rating subjective feelings. Br. J. Med. Psychol. 47 (1974), 211–218.
5. Brooks, J.C., Beckmann, C.F., Miller, K.L., Wise, R.G., Porro, C.A., Tracey, I., Jenkinson, M., Physiological noise modelling for spinal functional magnetic resonance imaging studies. Neuroimage 39 (2008), 680–692.
6. Brooks, J.C., Faull, O.K., Pattinson, K.T., Jenkinson, M., Physiological noise in brainstem FMRI. Front. Hum. Neurosci., 7, 2013, 623.
7. Cohen, E.R., Ugurbil, K., Kim, S.G., Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J. Cereb. Blood Flow Metab. 22 (2002), 1042–1053.
8. Craig, A.D.B., How do you feel-now? The anterior insula and human awareness. Nat. Rev. Neurosci. 10 (2009), 59–70.
9. Currow, D.C., Abernethy, A.P., Allcroft, P., Banzett, R.B., Bausewein, C., Booth, S., Carrieri-Kohlman, V., Davidson, P., Disler, R., Donesky, D., Dudgeon, D., Ekstrom, M., Farquhar, M., Higginson, I., Janssen, D., Jensen, D., Jolley, C., Krajnik, M., Laveneziana, P., McDonald, C., Maddocks, M., Morelot-Panzini, C., Moxham, J., Mularski, R.A., Noble, S., O'Donnell, D., Parshall, M.B., Pattinson, K., Phillips, J., Ross, J., Schwartzstein, R.M., Similowski, T., Simon, S.T., Smith, T., Wells, A., Yates, P., Yorke, J., Johnson, M.J., The need to research refractory breathlessness. Eur. Respir. J. 47 (2016), 342–343.
10. Currow, D.C., Quinn, S., Greene, A., Bull, J., Johnson, M.J., Abernethy, A.P., The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea. J. Palliat. Med. 16 (2013), 881–886.
11. De Peuter, S., Van Diest, I., Lemaigre, V., Li, W., Verleden, G., Demedts, M., Van den Bergh, O., Can subjective asthma symptoms be learned?. Psychosom. Med. 67 (2005), 454–461.
12. De Peuter, S., Van Diest, I., Lemaigre, V., Verleden, G., Demedts, M., Van den Bergh, O., Dyspnea: the role of psychological processes. Clin. Psychol. Rev. 24 (2004), 557–581.
13. Eichenbaum, H., Lipton, P.A., Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus 18 (2008), 1314–1324.
14. Eippert, F., Bingel, U., Schoell, E., Yacubian, J., Buchel, C., Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans. J. Neurosci. 28 (2008), 5465–5472.
15. Eippert, F., Bingel, U., Schoell, E.D., Yacubian, J., Klinger, R., Lorenz, J., Buchel, C., Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63 (2009), 533–543.
16. Ekstrom, M.P., Abernethy, A.P., Currow, D.C., The management of chronic breathlessness in patients with advanced and terminal illness. BMJ, 349, 2015, g7617.
17. Fanselow, M.S., Pavlovian conditioning, negative feedback, and blocking: mechanisms that regulate association formation. Neuron 20 (1998), 625–627.
18. Faull, O.K., Jenkinson, M., Clare, S., Pattinson, K.T., Functional subdivision of the human periaqueductal grey in respiratory control using 7 tesla fMRI. Neuroimage 113 (2015), 356–364.
19. Faull, O.K., Jenkinson, M., Ezra, M., Pattinson, K.T., Conditioned respiratory threat in the subdivisions of the human periaqueductal gray. Elife, 2016, 5 pii: e12047.
20. Favaroni Mendes, L.A., Menescal-de-Oliveira, L., Role of cholinergic, opioidergic and GABAergic neurotransmission of the dorsal hippocampus in the modulation of nociception in guinea pigs. Life Sci. 83 (2008), 644–650.
21. Glover, G.H., Li, T.Q., Ress, D., Image-based method for retrospective correction of physiological motion effects in fMRI: retroicor. Magn. Reson. Med. 44 (2000), 162–167.
22. Griffanti, L., Salimi-Khorshidi, G., Beckmann, C.F., Auerbach, E.J., Douaud, G., Sexton, C.E., Zsoldos, E., Ebmeier, K.P., Filippini, N., Mackay, C.E., Moeller, S., Xu, J., Yacoub, E., Baselli, G., Ugurbil, K., Miller, K.L., Smith, S.M., ICA-based artefact removal and accelerated fMRI acquisition for improved resting state network imaging. Neuroimage 95 (2014), 232–247.
23. Handwerker, D.A., Ollinger, J.M., D'Esposito, M., Variation of BOLD hemodynamic responses across subjects and brain regions and their effects on statistical analyses. Neuroimage 21 (2004), 1639–1651.
24. Harvey, A.K., Pattinson, K.T., Brooks, J.C., Mayhew, S.D., Jenkinson, M., Wise, R.G., Brainstem functional magnetic resonance imaging: disentangling signal from physiological noise. J. Magn. Reson. Imaging 28 (2008), 1337–1344.
25. Hayen, A., Herigstad, M., Kelly, M., Okell, T.W., Murphy, K., Wise, R.G., Pattinson, K.T., The effects of altered intrathoracic pressure on resting cerebral blood flow and its response to visual stimulation. Neuroimage 66 (2012), 479–488.
26. Hayen, A., Herigstad, M., Pattinson, K.T., Understanding dyspnea as a complex individual experience. Maturitas 76 (2013), 45–50.
27. Hayen, A., Herigstad, M., Wiech, K., Pattinson, K.T., Subjective evaluation of experimental dyspnoea-effects of isocapnia and repeated exposure. Respir. Physiol. Neurobiol. 208 (2015), 21–28.
28. Herigstad, M., Hayen, A., A., R., Pattinson, K.T.S., Development of a dyspnoea word cue set for studies of emotional processing in COPD. Respir. Physiol. Neurobiol. 223 (2016), 37–42.
29. Herigstad, M., Hayen, A., Evans, E., Hardinge, F.M., Davies, R.J., Wiech, K., Pattinson, K.T., Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest 148 (2015), 953–961.
30. Herigstad, M., Hayen, A., Wiech, K., Pattinson, K.T., Dyspnoea and the brain. Respir. Med. 105 (2011), 809–817.
31. Janssens, T., Verleden, G., De Peuter, S., Van Diest, I., Van den Bergh, O., Inaccurate perception of asthma symptoms: a cognitive-affective framework and implications for asthma treatment. Clin. Psychol. Rev. 29 (2009), 317–327.
32. Jenkinson, M., Bannister, P., Brady, M., Smith, S., Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17 (2002), 825–841.
33. Jones, A.K., Qi, L.Y., Fujirawa, T., Luthra, S.K., Ashburner, J., Bloomfield, P., Cunningham, V.J., Itoh, M., Fukuda, H., Jones, T., In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography. Neurosci. Lett. 126 (1991), 25–28.
34. Kelly, R.E. Jr., Alexopoulos, G.S., Wang, Z., Gunning, F.M., Murphy, C.F., Morimoto, S.S., Kanellopoulos, D., Jia, Z., Lim, K.O., Hoptman, M.J., Visual inspection of independent components: defining a procedure for artifact removal from fMRI data. J. Neurosci. Methods 189 (2010), 233–245.
35. LaBar, K.S., LeDoux, J.E., Spencer, D.D., Phelps, E.A., Impaired fear conditioning following unilateral temporal lobectomy in humans. J. Neurosci. 15 (1995), 6846–6855.
36. Lansing, R.W., Gracely, R.H., Banzett, R.B., The multiple dimensions of dyspnea: review and hypotheses. Respir. Physiol. Neurobiol. 167 (2009), 53–60.
37. Leknes, S., Tracey, I., A common neurobiology for pain and pleasure. Nat. Rev. Neurosci. 9 (2008), 314–320.
38. Leppa, M., Korvenoja, A., Carlson, S., Timonen, P., Martinkauppi, S., Ahonen, J., Rosenberg, P.H., Aronen, H.J., Kalso, E., Acute opioid effects on human brain as revealed by functional magnetic resonance imaging. Neuroimage 31 (2006), 661–669.
39. Ley, R., Respiratory psychophysiology and behavior modification. Behav. Modif. 25 (2001), 491–494.
40. Luchtmann, M., Jachau, K., Tempelmann, C., Bernarding, J., Alcohol induced region-dependent alterations of hemodynamic response: implications for the statistical interpretation of pharmacological fMRI studies. Exp. Brain Res. 204 (2010), 1–10.
41. MacIntosh, B.J., Pattinson, K.T., Gallichan, D., Ahmad, I., Miller, K.L., Feinberg, D.A., Wise, R.G., Jezzard, P., Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J. Cereb. Blood Flow Metab. 28 (2008), 1514–1522.
42. McGaraughty, S., Heinricher, M.M., Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity. Pain 96 (2002), 153–162.
43. McNally, G.P., Pigg, M., Weidemann, G., Blocking, unblocking, and overexpectation of fear: a role for opioid receptors in the regulation of Pavlovian association formation. Behav. Neurosci. 118 (2004), 111–120.
44. Minto, C.F., Schnider, T.W., Egan, T.D., Youngs, E., Lemmens, H.J., Gambus, P.L., Billard, V., Hoke, J.F., Moore, K.H., Hermann, D.J., Muir, K.T., Mandema, J.W., Shafer, S.L., Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86 (1997), 10–23.
45. Minto, C.F., Schnider, T.W., Shafer, S.L., Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 86 (1997), 24–33.
46. Mitsis, G.D., Governo, R.J., Rogers, R., Pattinson, K.T., The effect of remifentanil on respiratory variability, evaluated with dynamic modeling. J. Appl. Physiol. 106 (2009), 1038–1049.
47. Muthukumaraswamy, S.D., Evans, C.J., Edden, R.A., Wise, R.G., Singh, K.D., Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition. Hum. Brain Mapp. 33 (2012), 455–465.
48. Okell, T.W., Chappell, M.A., Kelly, M.E., Jezzard, P., Cerebral blood flow quantification using vessel-encoded arterial spin labeling. J. Cereb. Blood Flow Metab. 33 (2013), 1716–1724.
49. Oxberry, S.G., Bland, J.M., Clark, A.L., Cleland, J.G., Johnson, M.J., Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough. J. Palliat. Med. 16 (2013), 250–255.
50. Oxley, R., Macnaughton, J., Inspiring change: humanities and social science insights into the experience and management of breathlessness. Curr. Opin. Support Palliat. Care 10 (2016), 256–261.
51. Palermo, S., Benedetti, F., Costa, T., Amanzio, M., Pain anticipation: an activation likelihood estimation meta-analysis of brain imaging studies. Hum. Brain Mapp. 36 (2015), 1648–1661.
52. Pattinson, K., Functional brain imaging in respiratory medicine. Thorax 70 (2015), 598–600.
53. Pattinson, K.T., Opioids and the control of respiration. Br. J. Anaesth. 100 (2008), 747–758.
54. Pattinson, K.T., Governo, R.J., MacIntosh, B.J., Russell, E.C., Corfield, D.R., Tracey, I., Wise, R.G., Opioids depress cortical centers responsible for the volitional control of respiration. J. Neurosci. 29 (2009), 8177–8186.
55. Pattinson, K.T., Johnson, M.J., Neuroimaging of central breathlessness mechanisms. Curr. Opin. Support Palliat. Care 8 (2014), 225–233.
56. Pattinson, K.T., Rogers, R., Mayhew, S.D., MacIntosh, B.J., Lee, M.C., Wise, R.G., Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. Anesth. Analg. 106:347 (2008), 347–348.
57. Pattinson, K.T., Rogers, R., Mayhew, S.D., Tracey, I., Wise, R.G., Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia. J. Cereb. Blood Flow Metab. 27 (2007), 414–423.
58. Pattinson, K.T., Wise, R.G., Imaging the respiratory effects of opioids in the human brain. Adv. Exp. Med. Biol. 903 (2016), 145–156.
59. Peiffer, C., Morphine-induced relief of dyspnea: what are the mechanisms?. Am. J. Respir. Crit. Care Med. 184 (2011), 867–869.
60. Petrovic, P., Kalso, E., Petersson, K.M., Ingvar, M., Placebo and opioid analgesia- imaging a shared neuronal network. Science 295 (2002), 1737–1740.
61. Phelps, E.A., Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr. Opin. Neurobiol. 14 (2004), 198–202.
62. Phelps, E.A., LeDoux, J.E., Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48 (2005), 175–187.
63. Ploner, M., Lee, M.C., Wiech, K., Bingel, U., Tracey, I., Prestimulus functional connectivity determines pain perception in humans. Proc. Natl. Acad. Sci. USA 107 (2010), 355–360.
64. Price, D.D., Von der Gruen, A., Miller, J., Rafii, A., Price, C., A psychophysical analysis of morphine analgesia. Pain 22 (1985), 261–269.
65. Radloff, L.S., The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
66. Ray, W.A., Chung, C.P., Murray, K.T., Hall, K., Stein, C.M., Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. Jama 315 (2016), 2415–2423.
67. Robertson, J.A., Purple, R.J., Cole, P., Zaiwalla, Z., Wulff, K., Pattinson, K.T., Sleep disturbance in patients taking opioid medication for chronic back pain. Anaesthesia 71 (2016), 1296–1307.
68. Rocker, G.M., Simpson, A.C., Joanne Young, B., Horton, R., Sinuff, T., Demmons, J., Margaret Donahue, M.M., Hernandez, P., Marciniuk, D., Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes. CMAJ Open 1 (2013), E27–E36.
69. Salimi-Khorshidi, G., Douaud, G., Beckmann, C.F., Glasser, M.F., Griffanti, L., Smith, S.M., Automatic denoising of functional MRI data: combining independent component analysis and hierarchical fusion of classifiers. Neuroimage 90 (2014), 449–468.
70. Sandkühler, J., Lee, J., How to erase memory traces of pain and fear. Trends Neurosci. 36 (2013), 343–352.
71. Sesack, S.R., Grace, A.A., Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology 35 (2010), 27–47.
72. Smith, S.M., Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002), 143–155.
73. Spielberger, C.D., 2010. State-Trait Anxiety Inventory. In: The Corsini Encyclopedia of Psychology. John Wiley & Sons, Inc.
74. Tyrer, P., Eilenberg, T., Fink, P., Hedman, E., Tyrer, H., Health anxiety: the silent, disabling epidemic. BMJ, 353, 2016, i2250.
75. Vozoris, N.T., Wang, X., Fischer, H.D., Bell, C.M., O'Donnell, D.E., Austin, P.C., Stephenson, A.L., Gill, S.S., Rochon, P.A., Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur. Respir. J. 48 (2016), 683–693.
76. Wanigasekera, V., Lee, M.C., Rogers, R., Hu, P., Tracey, I., Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans. J. Neurosci. 31 (2011), 2835–2842.
77. Wanigasekera, V., Lee, M.C., Rogers, R., Kong, Y., Leknes, S., Andersson, J., Tracey, I., Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects. Proc. Natl. Acad. Sci. USA 109 (2012), 17705–17710.
78. Wiech, K., Ploner, M., Tracey, I., Neurocognitive aspects of pain perception. Trends Cogn. Sci. 12 (2008), 306–313.
79. Wiech, K., Tracey, I., The influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 47 (2009), 987–994.
80. Winkler, A.M., Ridgway, G.R., Webster, M.A., Smith, S.M., Nichols, T.E., Permutation inference for the general linear model. Neuroimage 92 (2014), 381–397.
81. Wise, R.G., Pattinson, K.T., Bulte, D.P., Chiarelli, P.A., Mayhew, S.D., Balanos, G.M., O'Connor, D.F., Pragnell, T.R., Robbins, P.A., Tracey, I., Jezzard, P., Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J. Cereb. Blood Flow Metab. 27 (2007), 1521–1532.
82. Wise, R.G., Rogers, R., Painter, D., Bantick, S., Ploghaus, A., Williams, P., Rapeport, G., Tracey, I., Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage 16 (2002), 999–1014.
83. Wise, R.G., Williams, P., Tracey, I., Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain. Neuropsychopharmacology 29 (2004), 626–635.
84. Woolrich, M.W., Behrens, T.E., Smith, S.M., Constrained linear basis sets for HRF modelling using Variational Bayes. Neuroimage 21 (2004), 1748–1761.
85. Woolrich, M.W., Behrens, T.E.J., Beckmann, C.F., Jenkinson, M., Smith, S.M., Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21 (2004), 1732–1747.
86. Zaman, J., Vlaeyen, J.W., Van Oudenhove, L., Wiech, K., Van Diest, I., Associative fear learning and perceptual discrimination: a perceptual pathway in the development of chronic pain. Neurosci. Biobehav. Rev. 51 (2015), 118–125.
87. Zubieta, J.K., Smith, Y.R., Bueller, J.A., Xu, Y., Kilbourn, M.R., Jewett, D.M., Meyer, C.R., Koeppe, R.A., Stohler, C.S., Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001), 311–315.